Related Experiment Video
Updated: Jan 5, 2026
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
[Key points of the announcement for metastatic prostate cancer]
J-P Bastié1, X Gamé1, M Roumiguié1
1Département d'urologie, transplantation rénale et andrologie, hôpital Rangueil, TSA50032, 31059 Toulouse, France.
Objective:
To know the key points of the diagnosis announcement for metastatic prostate cancer.
Materials And Methods:
Free interviews with patients and their relatives over a period of five years. Interviews in nurse out patient clinics, and coordination of complex care pathways with an active line of 350 patients per year.
Results:
The announcement of prostate cancer remains pejorative, regardless of the disease stage. It is even more traumatic when the patient has metastases, meaning for them, difficult days, heavy treatments and a considered compromised life expectancy.
Conclusion:
The announcement program frames the management of patients. It allows to weight the impact of the initial trauma and establish between the patient and all the medical and paramedical teams a therapeutic pact that opens on a life project.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...